Dr. Jonathan D. Wolfe, MD
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Medical school
- Vanderbilt University School of Medicine (2014)
- Years since graduation
- 12
- In the NPI registry since
- 2014
- Medicare patients seen, 2024
- 90
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2014Medical school: Vanderbilt University School of Medicine
- 2014Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
PA license MD481444 -
Critical Care Medicine (Internal Medicine) Physician
PA license MD481444
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- UPMC Presbyterian Shadyside Pittsburgh, PA
- Magee Womens Hospital of UPMC Health System Pittsburgh, PA
- UPMC St Margaret Pittsburgh, PA
Medical groups
- University of Pittsburgh Physicians (4,236 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 90
- Services billed
- 270
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Critical care, first 30-74 minutes | 39 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Pittsburgh, PA | 32 |
| Rosuvastatin Calcium Other prescribers in Pittsburgh, PA | 29 |
| Entresto (sacubitril/valsartan) Other prescribers in Pittsburgh, PA | 23 |
| Jardiance (empagliflozin) Other prescribers in Pittsburgh, PA | 20 |
| Metoprolol Succinate Other prescribers in Pittsburgh, PA | 18 |
| Atorvastatin Calcium Other prescribers in Pittsburgh, PA | 13 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 13 payments worth $663 in total to this clinician.
| Abiomed | $274 |
|---|---|
| Boston Scientific Corporation | $184 |
| Shockwave Medical, Inc | $103 |
| Amgen Inc. | $60.32 |
| E.r. Squibb & Sons, L.l.c. | $20.89 |
| Botanix Sb Inc | $20.51 |
| Food and Beverage | $663 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $3,537 in research payments for these studies, mostly to the institutions running them.
- A phase 3 randomized doubleblind 52WEEK placebocontrolled multicenter study with a doubleblind 52WEEK extension period with randomized dose updose down titration investigating the efficacy safety and tolerability of r…
Pfizer Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.